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RESEARCH ARTICLE
PEG3 Interacts with KAP1 through KRAB-A
Hongzhi He, An Ye, Hana Kim, Joomyeong Kim*




Peg3 (Paternally Expressed Gene 3) is an imprinted gene that encodes a zinc finger DNA-
binding protein. Peg3 itself is localized in the middle of a KRAB-A (Kruppel-Associated Box)
zinc finger gene cluster. The amino acid sequence encoded by its exon 7 also shows
sequence similarity to that of KRAB-A, suggesting Peg3 as a KRAB-containing zinc finger
gene. As predicted, the PEG3 protein was co-immunoprecipitated with KAP1, a co-repres-
sor that interacts with KRAB-A. A series of follow-up experiments further demonstrated that
the exon 7 of PEG3 is indeed responsible for its physical interaction with KAP1. ChIP and
promoter assays also indicated that PEG3 likely controls its downstream genes through the
KAP1-mediated repression mechanism. Overall, the current study identifies PEG3 as a
KRAB-containing zinc finger protein that interacts with the co-repressor protein KAP1.
Introduction
Peg3 (Paternally Expressed Gene 3) is an imprinted gene that encodes a zinc finger DNA-bind-
ing protein [1, 2]. As an imprinted gene, the genomic region surrounding the promoter of
Peg3 is usually methylated during oogenesis, thus the paternal allele is mainly expressed and
functional in somatic cells [3–5]. Mutagenesis experiments indicated that this gene is involved
in controlling the fetal growth rates and nurturing behaviors of placental mammals [6, 7].
Consistent with this, Peg3 is highly expressed in embryos, placenta and neuronal cells [5, 8, 9].
In humans, PEG3 has been often identified as one of the epigenetically affected genes in several
cancers, including ovarian and breast cancers, thus regarded as a potential tumor suppressor
[10–12]. At the molecular level, the protein encoded by this imprinted gene is known to bind
to a large number of genomic targets as a DNA-binding transcription factor [1, 2]. Recent
studies also revealed that this protein functions as a repressor controlling the transcriptional
rates of its downstream genes [1, 2]. This has been further supported by the observation that
the mutant embryos lacking PEG3 tend to de-repress several placenta-specific gene families in
the brain [7]. However, the detailed mechanisms for the predicted repression are currently
unknown.
Peg3 is localized in the middle of a large zinc finger gene cluster in human chromosome
19q13.4/proximal mouse chromosome 7 [9]. This gene cluster spans a two megabase pair (bp)
genomic distance, and contains more than 50 individual zinc finger genes [9]. In fact, its
immediate neighbors are also another zinc finger genes with genomic imprinting, including
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Zim1, Zim2, Zim3 and Zfp264 [13–15]. The zinc finger genes in this cluster all share a similar
protein domain structure, which consists of the KRAB-A (Kruppel-Associated Box A) domain
at the N-terminus and the Cys2His2-Kruppel-type zinc finger domain at the C-terminus [16,
17]. The C2H2 zinc finger domain is responsible for DNA binding, whereas the KRAB-A
domain is responsible for the physical interaction and subsequent recruitment of another pro-
tein called KAP1 (Kruppel-Associated Protein 1) [18]. KAP1 is a well-known co-repressor
that interacts with several epigenetic modification proteins, including LSD1 (Lysine-Specific
Demethylase 1), HDACs (Histone Deacetylases), SETDB1 (H3K9 histone methytransferase),
and DNMT3A (de novo DNA methytransferase 3A) [19, 20]. Thus, the zinc finger genes con-
taining the KRAB-A domain are thought to exert their repression functions through KAP1
[20]. Given the close localization to the other zinc finger genes, it has been believed that Peg3
might have originated from a similar zinc finger gene during mammalian evolution, and that
the repression roles played by PEG3 might be also mediated through similar mechanisms,
which involve the co-repressor KAP1 [21].
In the current study, we performed a series of evolutionary and in vitro analyses to test
whether PEG3 interacts with and exerts its repression roles through KAP1. According to the
results, PEG3 indeed contains a divergent KRAB-A domain as one of 5’-side small exons, con-
firming the evolutionary origin of Peg3 as a KRAB zinc finger gene. Furthermore, this diver-
gent KRAB-A domain of PEG3 is still functional as a subdomain that interacts with the co-
repressor KAP1. More detailed results are presented below.
Results
Identification of the KRAB-A domain within PEG3
The amino acid sequence of mouse PEG3 was used as a probe to retrieve the protein sequences
of PEG3 from the draft-stage genome sequences of the other mammals. This series of database
searches successfully identified PEG3 sequences from the majority of 45 placental mammals,
but none from the other vertebrates, such as opossum, platypus, avian, reptiles and fishes. This
suggests that the Peg3 locus may have been formed after the split of placental mammals from
the other vertebrates. More than a half of these identified sequences are full-length sequences
as compared to the ORF (Open Reading Frame) of mouse PEG3. Their exon structures are
also very similar to that of the mouse Peg3 locus: 9 exons are distributed throughout the 30-kb
genomic region of each species (Fig 1). Ten of these sequences representing several eutherian
lineages were selected and used for the evolutionary analyses of the current study (S1 File).
Multiple sequence alignment of the identified PEG3s derived the following observations
(S2 File). First, twelve C2H2 zinc finger motifs (hereafter referred to as ZF) are found within
the C-terminal region of the majority of the identified PEG3 sequences. These identified ZFs
are all localized in the C-terminal 1,000 amino acid long region, which is encoded within the
last exon, Exon9. The conservation levels of several ZF motifs (ZF1, 3, 4, 7, 11, 12) are much
greater than those from the remaining ZF motifs. In fact, some of ZF motifs have been degen-
erated in a couple of individual species, including ZF2 for cow and horse. This indicated that
individual ZF motifs might have been under the different levels of functional selection during
evolution. Second, the alignments also identified several regions of the conserved domains that
are localized between individual ZF motifs. These include two proline-rich motifs: the first
one between ZF5 and 6 and the second one between ZF10 and 11. The first one appears to be
rodent-specific: it is found only within mouse and rat. In contrast, the second one is found in
all of the mammals examined so far, indicating high levels of functional constraints on this
particular subdomain. The amino acid sequences of Exon3 also show high levels of sequence
identity to a known motif termed the SCAN box, which is also associated with C2H2 Kruppel-
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type zinc finger proteins [16, 17]. Interestingly, Exon3 of rodent PEG3s do not have a proper
ATG start codon that is located upstream of Exon3. Thus, it is unlikely that rodent PEG3s
have this SCAN box as part of their ORFs. Consistent with this, the amino acid sequences of
Exon3 of mouse and rat PEG3 show high levels of divergence as compared to those of the
remaining mammals, suggesting that rodent PEG3s might have lost this subdomain.
The multiple sequence alignments also showed high levels of conservation in the amino
acid sequences of Exon4 through 8. The sequences spanning from Exon4 through 6 showed
on average 64.2, 84.8, 66.2%, respectively, between individual mammal sequences. In contrast,
Exon7 and 8 show much higher levels of sequence conservation, on average 82.4 and 94.2%
sequence identity, respectively. An independent database search using the sequence of Exon8
did not yield any hint regarding its potential connection to known domains, thus Exon8 is
regarded as a novel motif unique to the PEG3 protein. However, a similar search with Exon7
derived an unexpected discovery that the 9 amino-acid-long motif found at the C terminus of
Exon7 is very similar to that of KRAB-A domain, which has been compared with the KRAB-A
domain of Zim1 (Fig 2). Yet, this small motif is well conserved among all of the mammalian
PEG3s, suggesting potential functional selection during evolution. Although the conserved
region is relatively short, the observed similarity suggests that Exon7 might have been a
KRAB-A domain as part of the ancestral locus of mammalian Peg3. Taken together, this series
of evolutionary analyses identified full-length sequences of mammalian PEG3 and also a short
motif within Exon7, which shows sequence similarity to the KRAB-A domain. Thus, it is most
likely that the modern Peg3 locus might have originated from an ancestral KRAB-A zinc finger
gene during mammalian evolution.
Identification of the potential interacting partners of PEG3
We performed a series of co-immunoprecipitation experiments to identify potential interact-
ing partners of the PEG3 protein (Fig 3). This series of experiments utilized a set of MEF
(Mouse Embryonic Fibroblast) cells, wild-type (WT) and knockout (KO), which were derived
from the 14.5-dpc (days post coitum) embryos of the crossing between male heterozygotes for
the Peg3CoKO (conditional KO-ready) allele and female breeders [7]. The Peg3CoKO allele is a
mutant allele truncating the transcription of the Peg3 locus. Since Peg3 is expressed mainly
Fig 1. Evolutionary conservation of mammalian PEG3 proteins. The exon structure of mouse Peg3 is
presented with boxes indicating individual exons. The conservation level of each exon at the amino acid
sequence level was calculated with Clustal Omega or Cobalt using the 10 representative PEG3 sequences,
which were further summarized with a scheme involving boxes with different colors. The sequence of Exon9
was further divided into protein subdomains, including 12 zinc finger motifs and two proline-rich motifs (P1 and
P2).
doi:10.1371/journal.pone.0167541.g001
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from the paternal allele, the KO embryos and corresponding MEFs inheriting the mutant allele
paternally are functionally null without any detectable levels of the PEG3 protein [7]. First, two
sets of the protein extracts prepared from WT and KO MEFs were individually immunopre-
cipitated with the polyclonal antibody raised against the PEG3 protein (Fig 3A). The subse-
quent immonoprecipitates, three WT and KO samples, were further analyzed with tandem
mass spectrometry (Fig 3B). According to the results, a set of 1,274 proteins was successfully
identified from each of 6 samples (S3 File). Comparison of the relative abundance of each pro-
tein between the WT and KO sets further identified 302 proteins that were differentially repre-
sented between the two sets. The raw spectral counts of these proteins were greater than 3,
and also their differential representation between the WT and KO sets were greater than 2.5.
Inspection of these proteins with gene ontology analysis revealed that 212 proteins are local-
ized in the cytoplasm whereas 64 proteins are in the nucleus of the cells. The remaining 26 pro-
teins are considered to be mitochondria-associated proteins. More careful inspection of raw
spectral counts also identified PEG3 as one of the most differentially represented proteins with
the relative abundance ratio between WT and KO being 1 to 0.102 (Student’s t test, p< 0.05).
This is consistent with the fact that the KO samples lack the PEG3 protein (Fig 3C). A group of
62 proteins also showed a similar pattern of differential representation with much lower levels
in KO than in WT. Some of these proteins are most likely the potential interacting partners of
PEG3 since the co-immunoprecipitation of these proteins with anti-PEG3 antibody were
detected in WT, but not in KO. Some of the noteworthy proteins include ACLY (ATP Citrate
Lyase), MEST (Mesoderm specific transcript), KAP1 and KDM1A (or LSD1). ACLY is the key
enzyme producing cytosolic acetyl-CoA, thus important for lipogenesis and cholesterogenesis
[22, 23]. On the other hand, KAP1 is a well-known co-repressor that interacts with numerous
zinc finger proteins through their KRAB-A domains [20]. It is also relevant to note that KAP1
functions as a glue protein brining together various histone modification enzymes, such as
LSD1. Thus, the detection of KAP1 and LSD1 is thought to be significant and also relevant to
the functions of the PEG3 protein since PEG3 contains a divergent KRAB-A domain (Fig 2).
Overall, this series of tandem mass spectrometry identified a large number of potential inter-
acting partners for the PEG3 protein. In particular, the potential interaction with the two
Fig 2. Identification of KRAB-A domain within PEG3. The amino acid sequences of Exon7 of mammalian
PEG3 were aligned using Clustal Omega (upper panel). The amino acid sequences of the KRAB-A exon of
mammalian ZIM1 were also similarly analyzed (lower panel). The 9-amino-acid-long region at the C-terminus
of Exon7 of PEG3 shows sequence similarity to that of the KRAB-A region as indicated with red. The
sequence on bottom indicates the consensus sequence of the KRAB-A domain.
doi:10.1371/journal.pone.0167541.g002
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proteins, KAP1 and LSD1, is thought to be the most relevant to the predicted functions of
PEG3, a DNA-binding protein with transcriptional repression.
KAP1 as an interacting partner of PEG3
The potential interaction between PEG3 and KAP1 was further tested using various in vitro
experiments described below. First, we repeated an independent series of immunoprecipita-
tion experiments with anti-PEG3 antibody using the protein extracts derived from MEF cells
(Fig 4C). The subsequent immunoprecipitates were analyzed with western blotting using anti-
KAP1 antibody. The results indicated that KAP1 was co-immunoprecipitated with anti-PEG3
antibody (the 3rd lane on the upper panel of Fig 4C). In contrast, KAP1 was not detectable in
the KO sample (the 4th lane on the upper panel of Fig 4C), indicating that the precipitation
and subsequent detection of KAP1 in WT was likely mediated through PEG3. We also
repeated a similar series of experiments with anti-LSD1 antibody. The results also showed co-
immunoprecipitation of LSD1 with anti-PEG3 antibody, supporting the possibility that PEG3
might also interact with LSD1 (the lower panel of Fig 4C). Second, this initial observation was
further followed up with another series of co-immunoprecipitation experiments using various
constructs expressing PEG3 and KAP1 (Fig 4A). The Neuro2A cells (N2A) were transfected
with the two following expression constructs: the first one containing the full-length PEG3
with the FLAG tag at the C-terminus whereas the second one containing the full-length KAP1
with the HA tag at the N-terminus. The protein extracts from the N2A cells that had been
transfected with these two constructs were individually immunoprecipitated with anti-FLAG
and anti-HA antibodies. These immunoprecipitates were subsequently analyzed with western
blotting using anti-KAP1 antibody (the upper panel on Fig 4D). The results indicated that
PEG3 was indeed co-immunoprecipitated with KAP1. This series of co-transfection
Fig 3. Identification of the potential interacting partners of PEG3. (A) The proteins extracts derived from
a set of WT (W1-3) and KO (K1-3) MEF cells were immunoprecipitated with anti-PEG3 antibody. The quality
of the isolated precipitates was first monitored through SDS-PAGE. The cell lysates (WT, KO) before the
immunoprecipitation were also included along with size markers (M). (B) The isolated precipitates were
further analyzed using a series of tandem mass spectrometry. A total of 1,274 proteins were successfully
identified from each of the 6 tested samples. The relative abundance (RA) of each protein was summarized
using a heat map showing different levels of abundance. (C) The relative abundance of three proteins in the
WT and KO samples were summarized with graphs with statistical significances.
doi:10.1371/journal.pone.0167541.g003
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experiments were repeated again with another set of two constructs: the first one containing
the full-length PEG3 whereas the second one containing the mutant version of PEG3 lacking
Exon7. The immunoprecipitates with anti-FLAG antibody, which was designed to pull-down
PEG3, detected high levels of KAP1 from the extracts transfected with the full-length PEG3,
but very low levels of KAP1 from those with the mutant version of PEG3 (the lower panel on
Fig 4D). This confirmed that the interaction between PEG3 and KAP1 is likely mediated
through Exon7, a divergent KRAB-A domain. This further suggests that the divergent
KRAB-A in PEG3 is still functional as a subdomain recruiting KAP1. As a control experiment,
we also performed a series of co-localization experiments with two expression constructs,
PEG3-FL-FLAG and KAP1-HA (Fig 4A). The immunostaning of the cells transfected with
these two constructs indicated that two proteins are localized within the nuclei but excluded
Fig 4. KAP1 as an interacting partner of PEG3. (A) A schematic representation indicates the exon
structure and the ORF of mouse PEG3. The current study used three constructs expressing mouse PEG3
and human KAP1: PEG3-FL, the full-length PEG3 with the FLAG tag at the C-terminus; PEG3-Del(Ex7), the
mutant version of mouse PEG3 lacking Exon7 with the FLAG tag at the C-terminus; KAP1, the full-length
KAP1 with the HA tag at the N-terminus. (B) Co-localization experiments. As a control experiment, the cells
were co-transfected with two constructs, PEG3-FL-FLAG and KAP1-HA constructs. The expression and
subsequent localization within the nuclei were individually visualized with anti-FLAG (left) and anti-HA
(middle) antibodies. These two images were later merged together (right). (C) The protein extracts derived
from MEF cells were individually immunoprecipitated with anti-PEG3 antibodies, and further analyzed with
western blotting using anti-KAP1 antibody (upper). A similar series of Co-IP experiments with anti-PEG3
antibody were repeated using the protein extracts from WT and KO MEFs, and later analyzed with western
blotting using anti-LSD1 antibody (lower). (D) Neuro2a cells were co-transfected with the constructs
expressing the full-length PEG3 and KAP1, immunoprecipitated with anti-FLAG and HA antibodies, and finally
analyzed with western blotting using anti-KAP1 antibody (upper). A similar series of Co-IP experiments were
repeated with two constructs expressing the full-length and mutant versions of PEG3. In this case, the
immunoprecipitates were analyzed with western blotting using anti-HA antibody (lower).
doi:10.1371/journal.pone.0167541.g004
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from the nucleolar areas, and further that some fraction of these two proteins are co-localized
within the nuclei (Fig 4B and S4 File). Overall, this series of in vitro experiments concluded
that PEG3 may interact with KAP1, and that this interaction may be mediated through Exon7.
PEG3 binding to its targets with KAP1
The potential interaction between PEG3 and KAP1 was also tested using a series of ChIP
experiments (Fig 5). According to the results from previous studies, PEG3 is known to bind to
the zinc finger exon of the adjacent imprinted gene Zim1 [24]. This binding of PEG3 is also
known to be responsible for the transcriptional repression of Zim1 [24]. However, the detailed
mechanisms for this repression have not been well characterized so far, although the zinc fin-
ger exon of Zim1, the target region of PEG3, is known to be marked with the H3K9me3 (Fig
5A). Since KAP1 is a potential co-repressor for PEG3, we tested whether PEG3 binds to the
zinc finger exon of Zim1 along with KAP1. This series of experiments also utilized a similar set
of MEF cells, WT and KO, as described above. The chromatin prepared from WT and KO
MEFs was first immunoprecipitated with anti-KAP1 antibody, and the isolated DNA was later
analyzed with quantitative PCR (Fig 5B). According to the results, the enrichment levels of sev-
eral regions within Zim1, R1 through 3, were lower in KO than those from WT. This indicated
that the binding of KAP1 to the Zim1 locus was reduced in the KO cells lacking PEG3. In par-
ticular, the R3 region, the known target region of PEG3, showed the lowest levels among the
four tested loci. As described above, this zinc finger exon is also known to be marked with
H3K9me3, requiring the involvement of KAP1 (Fig 5A). Thus, this suggests that PEG3 might
be the one recruiting KAP1 to the Zim1 locus. This further implies that the transcriptional
repression of Zim1 by PEG3 may be mediated through KAP1.
Fig 5. PEG3 binding to its targets with KAP1. The potential interaction of PEG3 and KAP1 was further
tested using ChIP experiments. PEG3 is known to bind to the zinc finger exon of Zim1, thus the 4 regions
covering the Zim1 locus were used for this analysis (A). The chromatin prepared from WT and KO MEFs were
precipitated with anti-KAP1 antibody, and the eluted DNA was subsequently analyzed using qPCR. The
results were summarized with graphs with statistical significance (B).
doi:10.1371/journal.pone.0167541.g005
PEG3 Interaction with KAP1
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Exon7 for the repression function of PEG3
We also tested potential roles played by Exon7 for the repression function of PEG3. According
to the previous studies, a number of genomic targets are known to be bound by PEG3, one of
which turned out to be the promoter region of another imprinted gene H19 [Ye et al, unpub-
lished]. Thus, we transfected Neuro2a and HEK293 cells with a series of luciferase constructs:
the first one without any promoter (Empty vector), the second one with the promoter of H19
(Fig 6A). As expected, the reporter activity of the H19-promoter construct was much higher
than that of the Empty construct (Fig 6B). The H19-promoter construct was again co-trans-
fected individually with the full-length PEG3 expression construct and also with the mutant
version of PEG3 construct lacking Exon7. As expected, the full-length PEG3 reduced the pro-
moter activity of H19 by 44%, confirming the repressor role played by PEG3 in the transcrip-
tion of H19. The mutant version of PEG3, on the other hand, did not show any difference
compared to the levels observed from the cells without any co-transfection of PEG3. This sug-
gests that the repression function of PEG3 is likely mediated through Exon7. A similar conclu-
sion was also derived from the results from the experiment set using HEK293 cells (data not
shown). However, the repressive effect by the full-length PEG3 was much milder than that
from the Neuro2a set, reducing the promoter activity of H19 by 21%. This is believed to be
caused by the reduced activity of KAP1 in HEK293 cells, which has been transformed by the
adenovirus E1B protein. Taken together, this series of in vitro promoter assays confirmed that
Exon7 plays a critical role in the repression function of PEG3.
Discussion
Through comparative genomic approaches, the current study has identified a divergent
KRAB-A domain as part of the ORF of mammalian PEG3. A series of follow-up experiments
further demonstrated that this divergent KRAB-A is indeed functional as a subdomain recruit-
ing KAP1, and also suggest that this domain might be critical for the repression function of
PEG3.
Peg3 has been relatively well known as an imprinted gene, but the functional aspect of this
gene, in particular the protein encoded by this gene, has not been well characterized so far.
Fig 6. Exon7 for the repression role of PEG3. A series of reporter assays were performed to test potential
roles played by Exon7 for the repression function of PEG3. This series of assays used two reporters:
promoterless basic (Empty) and H19-promoter-containing reporters (H19-prom). The H19-prom construct
was also co-transfected individually with the full-length and mutant versions of PEG3 (A). The graph
summarizes the results derived from this series of reporter assays. The obtained values of the luciferase
activity were first normalized with the amount of total proteins, and later compared to the value of the sample
transfected with the H19-prom construct only without the PEG3 expression construct. This series of
experiments were repeated with two independent trials (B).
doi:10.1371/journal.pone.0167541.g006
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According to the results, several subdomains are well conserved among all mammals, includ-
ing several zinc finger motifs (ZF1, 3, 4, 7, 11 and 12) and one proline-rich domain, consistent
with the prediction that the PEG3 protein is likely a DNA-binding protein (Fig 1). It is inter-
esting to note that the ZF motifs located in either N- or C-terminus are more conserved than
the other remaining ZFs. This is consistent with the pattern observed from the other Kruppel-
type zinc finger proteins [25, 26], and further suggests that those conserved ZF motifs are
likely involved in DNA binding. In contrast, the ZF motifs located in the middle seem to have
evolved very fast with minimum levels of functional constraints, thus these ZF motifs might
have adapted to some functions other than DNA binding, including protein-protein interac-
tion as seen in the other zinc finger proteins [27]. Besides the ZF motifs, three subdomains are
also well conserved, including a SCAN domain in Exon3, a divergent KRAB-A domain in
Exon7 and an unknown conserved domain in Exon8 (Figs 1 and 2). The identification of the
two subdomains, SCAN and KRAB-A, is informative for pinpointing the evolutionary origin
of the mammalian Peg3 locus. The Peg3 locus is surrounded by a large number of zinc finger
genes, the majority of which contain KRAB-A domains at their N-terminus [9]. Some of
these also have SCAN domains as part of their ORFs. Therefore, the detection of SCAN and
KRAB-A within the ORF of PEG3 strongly supports the possibility that the Peg3 locus might
have originated as an early member of this large zinc finger gene family. Since non-eutherian
mammals and the other vertebrates do not have similar sequences to Peg3, it is also likely that
the formation of Peg3 might have occurred right after the split of the eutherian from the other
vertebrates during mammalian evolution. Overall, the results suggest that the mammalian
Peg3 locus may have originated from an ancestral zinc finger gene with SCAN and KRAB-A
domains.
The PEG3 protein appears to contain a divergent KRAB-A domain, yet this domain has
been shown to interact with KAP1 (Figs 3, 4 and 5). Although this domain is quite divergent, a
series of unbiased proteomic analyses indicated that KAP1 is indeed one of the strongest can-
didates that were co-immunoprecipitated with PEG3 (Fig 3). Furthermore, the results from in
vitro experiments also demonstrated that this divergent KRAB-A is responsible for the interac-
tion between PEG3 and KAP1 (Fig 4). This further confirmed that this divergent KRAB-A is
still functional as a subdomain recruiting KAP1. The potential interaction between PEG3 and
KAP1 is also insightful for illuminating the unknown functions of the PEG3 protein. It has
been known that PEG3 functions as a transcriptional repressor for its downstream targets [1,
2]. Since KAP1 is known to interact with various histone-modifying proteins, it is reasonable
to predict that PEG3 might control its downstream targets through some of these histone-
modifying proteins. Two of the well-known such partners are SETDB1 and LSD1, which are
responsible for the methylation on H3K9 and the demethylation on H3K4me1 or 2, respec-
tively [19, 28]. In fact, the co-immunoprecipitation experiments confirmed that PEG3 might
also interact with LSD1 (Fig 4C). Therefore, it is possible that the functional outcome of the
binding of PEG3 to its targets might manifest through some of these histone modifications. In
that regard, it is relevant to point out the previous observation that several placenta-specific
gene families known to be repressed with H3K9me3 are, in fact, de-repressed in the embryos
lacking PEG3 [7]. This again supports the possibility that PEG3 might control its downstream
targets through histone modifications. Overall, although premature at the moment, these lines
of evidence strongly suggest that the repression function of PEG3 is likely mediated through
KAP1.
The results from tandem mass spectrometry revealed that many proteins might interact
with PEG3, including several nuclear proteins as well as various cytoplasmic proteins (Fig 3 and
S3 File). As a potential DNA-binding protein, the interaction of PEG3 with nuclear proteins
was expected. On the other hand, the potential interaction with cytoplasmic proteins was
PEG3 Interaction with KAP1
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unexpected at first. However, it is also feasible since several previous studies have already
reported that PEG3 is detected within the cytoplasm as part of the autophagosome in endothe-
lial cells and also associated with the outside membrane of mitochondria upon the commence-
ment of apoptosis [29, 30]. In that regard, some of potential interacting partners are noteworthy
based on their known functions. In particular, the potential interaction of PEG3 with ACLY
(ATP Citrate Lyase) is very intriguing in that this protein is a main enzyme controlling the rates
of the lipogenesis [22, 23]. One of the well-known phenotypes observed from Peg3 KO models
is that a large amount of adipocytes are known to be accumulated at the expense of muscle
mass [31]. Although more work needs to be done in the near future, it is reasonable to predict
that cytoplasmic PEG3 might be involved in controlling the lipogenesis through the physical
interaction with ACLY. Besides ACLY, several other enzymes are also potential interacting
partners, including HK2 (Hexokinase2). It is interesting to note that these proteins all seem to
be involved in controlling glycolysis or gluconeogenesis. The potential connection with these
enzymes appears to be consistent with the fact that PEG3 is involved in controlling energy
metabolism. Overall, a list of potential interacting partners of PEG3 provides several new direc-
tions for the future study of the PEG3 protein, not only as a DNA-binding protein but also as a
cytoplasmic protein controlling energy metabolism.
Materials and Methods
Ethics statement
All the experiments related to mice were performed in accordance with National Institutes of
Health guidelines for care and use of animals, and also approved by the Louisiana State Uni-
versity Institutional Animal Care and Use Committee (IACUC), protocol #16–060.
Database search and sequence analyses
A series of database searches were conducted using the BLAT program (http://genome.ucsc.
edu/cgi-bin/hgBlat) to obtain PEG3-related sequences. Mouse PEG3 (GenBank accession No.
NP_032843) was used as a query sequence to search sequence databases, including NCBI and
the Genome Browser at University of California Santa Cruz (http://genome.ucsc.edu/). The
10 representative PEG3 sequences from different mammals are included as S1 File. Multiple
sequence alignments were performed with Clustal Omega (http://www.ebi.ac.uk/Tools/msa/
clustalo/) and also with Cobalt (http://www.ncbi.nlm.nih.gov/tools/cobalt/re_cobalt.cgi). The
output from Cobalt using the 10 representative sequences is also included as S2 File.
Plasmid construction
The ORF of mouse PEG3, corresponding to amino acid residue 1–1,571 (GenBank accession
No. NP_032843), was amplified from the expression vector pCDNA-PEG3-FL [1] with the fol-
lowing two primers: BamHI-mPeg3-CDS-F(5’-ATATGGATTCATGTACCATCACGAAGA
CGACACC-3’)and EcoEV-mPeg3-CDS-R(5’-GAGTGATATCACCAGTGTGAGAATT
CTGGTGTCT-3’). The amplified fragment was cloned into the pCMV-3T3 vector (Agilent
Technologies), named pCMV-3T3-PEG3-FL. This construct, in short PEG3-FL, was use for
the expression of the full-length PEG3 with the FLAG tag at the C-terminus. The exon 7 of
PEG3 was deleted using a PCR scheme involving the two primers: BamHI-mPeg3-CDS-F and
XbaI-mPeg3-CDS-R (50-CTTCCTTTCTAGAGCTCTGCTTCTGG-3’). The added XbaI site
was ligated to another XbaI site that is already included in the ORF of mouse PEG3, resulting
in the deletion of the exon 7. The proper deletion and integrity of the final construct, named
PEG3-Del(Ex7), was confirmed through sequencing. The current study also used the construct
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pKH3-TRIM28 that is designed to express human KAP1 with 3 HA tags at the N-terminus
(Plasmid No. 45569, Addgene) [32].
Tissue culture and transfections. All cells were maintained in Dulbecco’s modified
Eagle’s medium (Cat. No. 10566–016, Life Technologies) containing 10% fetal bovine serum
(Cat. No. SH30088.03, Hyclone). Mouse embryonic fibroblast (MEF) cells were derived from
14.5-dpc embryos as described previously [24]. For Co-IP experiments, Neuro2a cells (CCL-
131, ATCC) in 6-well plates were co-transfected with pKH3-TRIM28 (KAP1) combined with
either the PEG3-FL or PEG3-Del(Ex7) constructs using the Lipofectmine 2000 method. The
transfected cells were incubated for 48 hours in 2.5 ml of medium before the planned Co-IP
experiments.
Immunoprecipitation and immunoblotting
The immunoprecipitation for tandem mass spectrometry used the following procedure. Wild
type and CoKO MEF cells in 100mm dish were collected by centrifugation, and the subsequent
pellets were lysed in 1 ml of the Pierce IP Lysis Buffer (Cat. No. 87787, Thermo Scientific) con-
taining 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 mM EDTA, 5% glycerol. The
prepared lysates were centrifuged at 4˚C for 15 mins at 12,000xg to remove cell debris. Each
cleared lysate from the wild type and CoKO cells was divided into 3 individual aliquots. For
the pre-clearing step, 50 μl of the protein A/G agarose bead (Cat. No. 2042, Thermo Scientific)
was added to each tube and incubated for 2 hours at 4˚C with gentle agitation. The samples
were centrifuged at 14,000xg at 4˚C for 10 mins, and the subsequent supernatants were used
for the planned immunoprecipitation with 5 μg of anti-PEG3 antibody (Cat. No. ab99252,
Abcam). After overnight incubation at 4˚C with gentle agitation, 50 μl of the protein A/G aga-
rose bead was added to each tube, and incubated for additional 4 hours at 4˚C. After the incu-
bation, the samples were centrifuged again to remove the supernatants, and the remaining
beads were washed three times with the lysis buffer. The proteins were eluted from the beads
with 50 μl of 5% acetic acid for 3 mins at room temperature. The recovery and quality of the
immunoprecipitated proteins were analyzed through SDS-PAGE followed by silver staining.
The immunoprecipitation for Co-IP experiments used the following procedure. Trans-
fected Neuro2a cells were washed on ice with PBS, and lysed in 1 ml of the Pierce IP Lysis
Buffer. The subsequent lysates were cleared with the centrifugation at 4˚C for 15 mins at
21,000×g. The cleared lysates were then subject to the immunoprecipitation using 1 μg of the
monoclonal anti-FLAG antibody (Cat. No. MA1-91878, Thermo Scientific) or anti-HA Epi-
tope Tag antibody (Cat. No. 26183, Thermo Scientific), followed by 20 μl of the goat anti-
mouse IgG beads to collect the immune complexes. After the wash with the lysis buffer, the
beads were heated in the SDS sample buffer. The eluted protein samples were separated by
SDS-PAGE, and transferred to Immun-Blot PVDF membrane (Bio-Rad). The membranes
were blotted with the monoclonal antibodies against KAP1 (Cat. No. ab10484, Abcam), LSD1
(Cat. No. ab37165, Abcam), or HA Epitope Tag, and then incubated with the HRP-conjugated
secondary antibody. The target proteins were visualized using North2South Chemilumines-
cent Substrate (Cat. No. 17295, Thermo Scientific) in the Chemidoc XRS documentation sys-
tem (Bio-Rad)
Double immunofluorescence staining for co-localization experiments
HeLa cells were transiently transfected with PEG3-FL-FLAG and KAP1-HA expression con-
structs. After 48 hour post-transfection, the cells were fixed in 4% paraformaldehyde for 15
minutes. The first primary antibody, anti-FLAG (Cat. No. MA1-91878, Thermo Scientific)
was diluted 1:1000 in blocking solution (Cat. No. B40942, Invitrogen) overnight in 4˚C with
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gentle rocking. After three washes in PBS, the cells were incubated at room temperature for 1
hour in HRP conjugated anti-mouse secondary antibody (Cat. No. B40942, Invitrogen) fol-
lowed by 5 minute incubation in Alexa Fluor tyramide (Cat. No. B40942, Invitrogen). Subse-
quently, the cells were incubated in the second primary antibody, anti-HA tag antibody (Cat.
No. 26183, Thermo Scientific), diluted 1:1000 in blocking solution overnight in 4˚C with gen-
tle rocking. The Alexa Fluor 488 (Cat. A11001, Invitrogen) were used as the subsequent sec-
ondary antibody at 1:200 dilution. The cells were imaged on Leica DM2500 microscope.
Protein identification by LC-MS/MS
The immunoprecipitated proteins with the anti-PEG3 antibody were separated on an SDS
gel, reduced with DTT, alkylated with iodoacetimide, and digested in-gel with trypsin. The
digested peptides were extracted from the gel, labeled with the TMT (Tandem Mass Tag)
reagent, and analyzed on an Orbitrap Fusion mass spectrometer (Thermo Fischer Scientific).
In brief, the peptides were separated using a gradient of 3 to 23% acetonitrile in 0.125% formic
acid over 180 minutes, detected (MS1) and quantified (MS3) in the Orbitrap. The peptides
were further sequenced (MS2) in the ion trap. MS2 spectra were searched using the SEQUEST
algorithm against the UniProt composite database derived from the mouse proteome contain-
ing its reversed complement and known contaminants. The peptide spectral matches were fil-
tered to a 1% false discovery rate (FDR) using the target-decoy strategy combined with linear
discriminant analysis. The proteins were filtered to a<1% FDR, and the proteins were quanti-
fied only from the peptides with the summed SN threshold of> = 100 and the isolation speci-
ficity of 0.5.
Chromatin ImmunoPrecipitation (ChIP)
Chromatins were prepared from MEF according to the method previously described [24]. In
brief, the homogenized samples were first cross-linked with 1% formaldehyde for 20 mins, and
then lysed with the buffer containing protease inhibitor cocktail (Cat. No. 539131, Millipore).
The released nuclei were fractionated with sonication to derive a pool of DNA fragments size-
ranging from 300 to 500 bp in length. The prepared chromatin was immunoprecipitated with
a commercial antibody against KAP1 (Cat. No. ab10484, Abcam). The immunoprecipitated
DNA was dissolved in 50 μl of TE for PCR analyses.
Promoter assays
The reporter assay used the following constructs. The modified version of the β-gal vector was
used as a control vector monitoring transfection efficiency [33]. The vector designed to test
promoter activity was modified from a commercial luciferase vector (PGL3, Promega). This
modified vector is promoterless, thus no promoter activity without any inserted DNA (Empty
vector). The promoter region of H19, 610 bp in length, was inserted into the NotI site of the
modified luciferase vector (H19-prom). For the luciferase reporter assay, Neuro2a and
HEK293 cells were cultured in DMEM medium with 10% fetal bovine serum, and plated in
6-well plates for transfection. For the control, the cells on one well were transfected with 1.0 μg
of the β-gal vector and 1.0 μg of the Empty vector. For the luciferase assay, the cells on each
well were also co-transfected with 1 μg of the β-gal vector, 1 μg of each luciferase vector and
0.5 μg of the expression vector containing the full-length or mutant versions of PEG3. Fresh
complete media was added 6 hours after the transfection, and the total cell lysates were har-
vested 48 hours later in 300 μl of the cell lysis buffer according to the previously published pro-
tocol [33]. The luciferase assay was performed in triplicates.
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Supporting Information
S1 File. This file contains amino acid sequences of 10 representative mammalian PEG3.
(RTF)
S2 File. This file contains the output of amino acid sequence alignment using 10 mamma-
lian PEG3s.
(PDF)
S3 File. This file contains the output of tandem mass spectrometry, which has been derived
from WT and KO MEFs.
(PDF)
S4 File. This file contains additional images that were derived from the immunostaining of
the cells that were co-transfected with PEG3-FL-FLAG and KAP1-HA constructs.
(TIF)
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